ID   EV-SCC-2
AC   CVCL_RK01
SY   EVSCC 2; EVSCC2; Eastern Virginia-Squamous Cell Carcinoma-2
DR   Wikidata; Q54832958
RX   PubMed=8552396;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
RX   PubMed=8552396;
RA   Patel A.M., Incognito L.S., Schechter G.L., Wasilenko W.J.,
RA   Somers K.D.;
RT   "Amplification and expression of EMS-1 (cortactin) in head and neck
RT   squamous cell carcinoma cell lines.";
RL   Oncogene 12:31-35(1996).
//
RX   PubMed=17312569; DOI=10.1002/hed.20478;
RA   Lin C.J., Grandis J.R., Carey T.E., Gollin S.M., Whiteside T.L.,
RA   Koch W.M., Ferris R.L., Lai S.Y.;
RT   "Head and neck squamous cell carcinoma cell lines: established models
RT   and rationale for selection.";
RL   Head Neck 29:163-188(2007).
//